Net Cash Provided by (Used in) Financing Activities in USD of BIO-TECHNE Corp from 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
BIO-TECHNE Corp quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2010 to Q3 2025.
  • BIO-TECHNE Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending September 30, 2025 was -$44.2M, a 282% decline year-over-year.
  • BIO-TECHNE Corp annual Net Cash Provided by (Used in) Financing Activities for 2025 was -$254M, a 107% decline from 2024.
  • BIO-TECHNE Corp annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$122M, a 641% decline from 2023.
  • BIO-TECHNE Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was $22.6M.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

BIO-TECHNE Corp Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$44.2M -$32.6M -282% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-05
Q3 2024 -$11.6M -$83.1M -116% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-05
Q3 2023 $71.5M +$103M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q3 2022 -$31.8M +$7.88M +19.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q3 2021 -$39.7M -$4.75M -13.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q3 2020 -$34.9M -$10.7M -43.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q3 2019 -$24.3M -$247M -111% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-06
Q3 2018 $223M +$273M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q3 2017 -$51M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q3 2013 -$9.9M +$846K +7.87% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-12
Q3 2012 -$10.7M +$10.8M +50.1% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q3 2011 -$21.6M -$10.6M -97.5% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q3 2010 -$10.9M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09

BIO-TECHNE Corp Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 -$254M -$132M -107% Jul 1, 2024 Jun 30, 2025 10-K 2025-08-22
2024 -$122M -$145M -641% Jul 1, 2023 Jun 30, 2024 10-K 2025-08-22
2023 $22.6M +$265M Jul 1, 2022 Jun 30, 2023 10-K 2025-08-22
2022 -$243M -$180M -288% Jul 1, 2021 Jun 30, 2022 10-K 2024-08-22
2021 -$62.6M +$121M +66% Jul 1, 2020 Jun 30, 2021 10-K 2023-08-23
2020 -$184M -$318M -237% Jul 1, 2019 Jun 30, 2020 10-K 2022-08-24
2019 $134M +$234M Jul 1, 2018 Jun 30, 2019 10-K 2021-08-25
2018 -$99.2M -$288M -152% Jul 1, 2017 Jun 30, 2018 10-K 2020-08-26
2017 $189M +$212M Jul 1, 2016 Jun 30, 2017 10-K/A 2019-11-06
2016 -$23.4M Jul 1, 2015 Jun 30, 2016 10-K 2018-08-27
2013 -$44.7M +$19.9M +30.9% Jul 1, 2012 Jun 30, 2013 10-K 2013-08-29
2012 -$64.6M -$28.3M -78.1% Jul 1, 2011 Jun 30, 2012 10-K 2013-08-29
2011 -$36.3M +$14.2M +28.2% Jul 1, 2010 Jun 30, 2011 10-K 2013-08-29
2010 -$50.5M Jul 1, 2009 Jun 30, 2010 10-K 2012-08-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.